Sid Parulkar

Corporate swag: Brand that speaks your Vision. Customized premium corporate apparel, Polo T shirts, pullover, sweat shirts etc

Corporate swag: Brand that speaks your Vision. Customized premium corporate apparel, Polo T shirts, pullover, sweat shirts etc

VentureBlick is the trusted Go Global partner for healthcare innovation. We connect key players worldwide to foster impactful collaborations, helping startups scale, SMEs with global expansion, and corporations in discovering new technologies on a global scale. Headquartered in Singapore, VentureBlick operates across major markets including Korea, India, and China. We offer tailored insights and on-the-ground support, powered by our local teams and a curated network of over 6,500 clinicians and domain experts across 30+ specialties in 60+ countries. We leverage our healthcare community and proprietary platform, VB Discovery, which serves as the “eyes and ears” of emerging healthcare innovations. VB Discovery maximises reach and efficiency, ensuring our clients stay at the forefront of industry trends. With a proven track record, we support a diverse portfolio of clients — from startups to large corporations — in achieving global growth. Our services span global expert insights, go-to-market strategies, open innovation and technology scouting, acceleration programmes, and healthcare partnerships. Visit www.ventureblick.com to learn more. Let the venture begin!

PAR Clinical was founded as a “Strategic life sciences consulting firm” with a focus on developing strategies for the healthcare industry to help improve patient lives. As a strategic life science consulting firm, we are structured to deliver a tailored operational solution to our clients to help them achieve successful organizational outcomes. Our tailored business solution is structured around two unique service models: 1)Strategic Consulting Model (Plug and Play Model): In this model, we act as an extension of your team to provide functional expertise within your organization: a)Functional Expertise: Start-ups require strong functional expertise and infrastructure to design and execute their clinical strategies. Support mission-critical challenges or problems that require a set of expertise which is missing at the inception phase of a company. PAR Clinical supports newly formed Biotech firms with expertise where they lack the muscle memory or in-house expertise to confidently execute their projects. b)Objective Analysis/Opinion: Our strategic consulting team can assist with objective analysis and decision making in scenarios where your drug development strategy requires a third-party opinion. PAR Clinical as a consulting firm can bring in an objective view on industry best practices, essentially leveraging their wider purview of how other companies have tackled similar problems. c)On-Demand Brains: Since start-up companies are too small they require an injection of smart people and "brains" to bring to bear the problem at hand. With PAR Clinical, infrastructure is already in place and since our teams have been working together as a unit for several years catering to different client needs it is a quick and seamless integration within your organization to focus on true challenges. 2) Contract Research Organization: Run your clinical trials/studies as boots on the ground with expertise in Regulatory, Clinical Operations and Biometrics.

Blueprint Medicines, a Sanofi company, is a fully integrated global biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including systemic mastocytosis and chronic urticaria, breast cancer and other solid tumors. Patients are at the center of our mission. We know that in order to make a difference in their lives, we must create an environment where our employees — also known as the Blue Crew — can do their best work. Our culture of transparency, curiosity and diversity empowers us to draw upon a wide range of backgrounds and perspectives to build a conscientious team dynamic. Ideas come from every member of the Blue Crew, from the executive team to new hires. Each day, our teams commit to approach one another with respect and trust: a simple promise that fosters an inclusive and collaborative spirit. We care deeply about the communities where we live and work, and we strive to make a profound impact where it matters most. Learn more about who we are and explore our career opportunities at https://www.blueprintmedicines.com/careers/. Read our community guidelines: https://www.blueprintmedicines.com/community-guidelines/.

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific progress, in an effort to advance healthcare. To learn more, visit www.iqvia.com.